Should you be paying attention to this ASX 200 investment manager?

Here's why I think Challenger Ltd (ASX: CGF) shares are worth serious consideration in 2020.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Challenger Ltd (ASX: CGF) shares are currently trading at $8.70, far below their high of $14.42 back in late 2017. However, since the beginning of the year they are up over 7% and around 24% over the past 6 months.

So, why the volatility? And should you be interested in owning Challenger shares?

What does Challenger do?

Challenger is a member of the S&P/ASX 200 Index (INDEXASX: XJO), with a market cap of just over $5 billion. The investment management firm manages $84 billion in assets and operates 2 core business divisions: life and funds management.

Funds management division

Challenger's funds management businesses targets the accumulation or retirement savings phase – in other words, those who are currently saving and investing for their retirement. This is achieved through investment products in its 2 services – Fidante Partners and Challenger Investment Partners.

Fidante works with investment professionals to help create, grow and support boutique fund management businesses, while Challenger Investments works globally in fixed income and real estate investments as well as derivative strategies.

Life division

Challengers APRA-regulated life division provides for the next stage of life – retirement. This business is the largest provider of annuities and guaranteed retirement income solutions in Australia. These annuities are a stream of fixed payments to individuals (often retirees), giving them a steady reliable income. 

How has Challenger performed recently?

Challenger has had a difficult couple of years. Interest rates declined and it saw a return to increased market volatility. It reported in the first half of FY19 a net profit after tax (NPAT) of just $6 million, which was down 97% on the prior corresponding period (pcp). However, in its most recent first quarter results it has re-affirmed its guidance for FY20 for NPAT of $500–550 million. This is roughly flat over FY19.

Challenger also reported a decrease in Australian annuity sales, however, total annuity sales were up 14% thanks to a 5 times increase in its Japanese annuities. These Japanese (MS Primary) annuity sales now represent 26% of total sales, up from 5% in the previous quarter.

Outlook

I like Challenger's outlook, given that the population aged over 65 is estimated to rise by 40% over the next decade. The vast majority of these people will retire or be looking to retire and many will look for a stable income.

There is also a change to the Australian Retirement Income Framework, which is set to be in place by 1 July this year. Here, the government is introducing a covenant that will require superannuation trustees to have a retirement income strategy in place for members. Challenger is welcoming this change and believes it will improve the standard of living for retirees by developing a retirement phase of superannuation.

Foolish takeaway

I believe these industry tail winds can see Challenger's annuity sales and funds under management grow materially over the next 10 years. Additionally, Challenger also offers an expected grossed-up dividend yield of 5.86% with a payout ratio of 45–50%.

Motley Fool contributor Michael Tonon owns shares of Challenger Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Three people gather around a large computer screen where they are looking at something that is captivating their interest with a graphic image of data and digital technology material superimposed to the right hand third of the image.
Share Market News

Here's how the ASX 200 market sectors stacked up last week

ASX tech shares led the market for a third consecutive week with a 4.63% increase.

Read more »

Mini house on a laptop.
Dividend Investing

Do ASX 200 dividend shares out-earn Aussie property?

We compare the forecast FY25 dividend yields of the top 10 ASX 200 companies to rental property yields.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Best Shares

Top ASX shares to buy with $500 in November 2024

$500 worth of ASX shares might not sound like a huge investment. But, to realise the benefits of compounding, you…

Read more »

A diverse group of people form a circle at a park and raise their arms together.
Share Market News

Here are the top 10 ASX 200 shares today

ASX investors ended the trading week on a high note this Friday...

Read more »

Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Catapult, De Grey Mining, Domino's, and Nufarm shares are charging higher

These shares are ending the week strongly. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »